NO20034873L - Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering - Google Patents

Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering

Info

Publication number
NO20034873L
NO20034873L NO20034873A NO20034873A NO20034873L NO 20034873 L NO20034873 L NO 20034873L NO 20034873 A NO20034873 A NO 20034873A NO 20034873 A NO20034873 A NO 20034873A NO 20034873 L NO20034873 L NO 20034873L
Authority
NO
Norway
Prior art keywords
dihydroxy
derivatives
stratriene
degree
formulations containing
Prior art date
Application number
NO20034873A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034873D0 (no
Inventor
Rebecca Jaine Davies
David Ganderton
David Andrew Lewis
Brian John Meakin
Gaetano Brambilla
Alessandra Ferraris
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20034873D0 publication Critical patent/NO20034873D0/no
Publication of NO20034873L publication Critical patent/NO20034873L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO20034873A 2002-03-01 2003-10-31 Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering NO20034873L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02004787A EP1340503A1 (de) 2002-03-01 2002-03-01 Lösung Aerosol Formulierung von Estern von 3,17-dihydroxy Oestratrien-Derivaten zur Lungenverabreichung
PCT/EP2003/001856 WO2003074058A1 (en) 2002-03-01 2003-02-24 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery

Publications (2)

Publication Number Publication Date
NO20034873D0 NO20034873D0 (no) 2003-10-31
NO20034873L true NO20034873L (no) 2003-12-23

Family

ID=27675680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034873A NO20034873L (no) 2002-03-01 2003-10-31 Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering

Country Status (9)

Country Link
US (1) US20050209207A1 (de)
EP (2) EP1340503A1 (de)
AT (1) ATE381339T1 (de)
AU (1) AU2003215588A1 (de)
BR (1) BR0303347A (de)
DE (1) DE60318182T2 (de)
ES (1) ES2297183T3 (de)
NO (1) NO20034873L (de)
WO (1) WO2003074058A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1100723A2 (en) * 2011-12-28 2013-06-28 Avidin Kft Use of estrogen derivatives for preparing medicament for the treatment of psychiatric diseases
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1099722A (en) * 1964-04-20 1968-01-17 Takeda Chemical Industries Ltd Aerosol
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US4315925A (en) * 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
ATE114112T1 (de) * 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
US6461591B1 (en) * 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
AU740758B2 (en) * 1997-10-28 2001-11-15 Vivus, Inc. Treatment of female sexual dysfunction
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents

Also Published As

Publication number Publication date
DE60318182T2 (de) 2008-12-04
WO2003074058A1 (en) 2003-09-12
EP1340503A1 (de) 2003-09-03
EP1480651B1 (de) 2007-12-19
ATE381339T1 (de) 2008-01-15
NO20034873D0 (no) 2003-10-31
AU2003215588A1 (en) 2003-09-16
EP1480651A1 (de) 2004-12-01
BR0303347A (pt) 2004-07-13
US20050209207A1 (en) 2005-09-22
ES2297183T3 (es) 2008-05-01
DE60318182D1 (de) 2008-01-31

Similar Documents

Publication Publication Date Title
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
CY1122851T1 (el) Υπερλεπτο σκευασμα φορμοτερολης
DK1389137T3 (da) Sammensætninger til lungelægemiddellevering af protein
DK0656207T3 (da) Aerosolformuleringer uden chlorfluorcarbonforbindelser
PT918507E (pt) Formulacoes em aerossol
SE0102276D0 (sv) Device and method for the administration of a medicament
GB9425160D0 (en) Medicaments
YU59899A (sh) Medicinski aerosolni proizvodi
CO4940408A1 (es) Composicion de aerosol farmaceutico
AU6633801A (en) Medicinal compositions for angiogenic therapy
GB0323684D0 (en) Improvements in or relating to organic compounds
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
IT1317720B1 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
WO2007022090A3 (en) Topical delivery with a carrier fluid
CO5200840A1 (es) Combinacion de sustancias activas con clonidina
NO20083759L (no) Doserings aerosoler for administrering av farmasoytiske preparater
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
BR0303347A (pt) Formulações de aerossol contendo ésteres de derivados de 3,17-diidroxi estratieno para deposição pulmonar
ATE286716T1 (de) Pharmazeutische formulierungen enthaltend salmeterol
BR0209578A (pt) Uso de um gatran ou de um derivado farmaceuticamente aceitável do mesmo, método de tratamento de fibrose pulmonar, e, formulação farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application